Cuprina (Cayman) Limited (CUPR)
NasdaqCM: CUPR
· Real-Time Price · USD
2.97
+0.05 (1.71%)
At close: Aug 18, 2026, 3:57 PM
Cuprina (Cayman) Limited (CUPR) Stock Price, Analysis & Data
1.71% (1D)
| Bid | n/a |
| Market Cap | 7.96M |
| Revenue (ttm) | 49.89K |
| Net Income (ttm) | -4.67M |
| Beta | n/a |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 2.00 |
| P/S (ttm) | 159.60 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 11,469 |
| Avg. Volume (20D) | 3,138,943 |
| Open | 2.82 |
| Previous Close | 2.92 |
| Day's Range | 2.72 - 3.02 |
| 52-Week Range | 1.76 - 19.60 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CUPR
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hyd...
Industry Medical Instruments & Supplies
Sector Healthcare
IPO Date Apr 10, 2025
Employees 10
Stock Exchange NasdaqCM
Ticker Symbol CUPR
Website https://www.cuprina.com.sg
Financial Performance
In 2025, Cuprina (Cayman)'s revenue was 49.89K, an increase of 3.26% compared to the previous year's 48.32K. Earnings were -4.67M, an increase of 199.48%.
Financial Statements